Brunei HCP Content - Molnupiravir

This website is intended for Brunei Healthcare Professionals only

Molnupiravir Capsule 200mg
Each capsule contains 200 mg molnupiravir
Each bottle contains 40 capsules

Have a question about an MSD product or want to report an Adverse Event or Quality Issue?

Adverse Events and Product Quality Complaints should be reported.

IF YOU ARE A HEALTHCARE PROFESSIONAL:
Report to MSD at Fax – +65-63966883 or Email – dpoc.singapore@msd.com.
Please add ‘4482-PLPA-001’ to your report.
For local health authority, please report:
Adverse event via nadrmc.dps@moh.gov.bn using the Suspected Adverse Drug Reaction Report Form
Quality Issue via productdefect.pharmacy@moh.gov.bn using the Medicinal Product Quality Reporting Form

For medical inquiries, contact MSD at dpoc.singapore@msd.com.

Authorization for molnupiravir is provided by Brunei Darussalam Medicines Control Authority via special approval during public health emergency or pandemic situation. This is only a temporary authorization and is not a marketing authorization.